Active, Not Recruiting
A Study of Rocbrutinib in Participants With Relapse or Refractory Mantle Cell Lymphoma
NCT05716087
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Anhui provincial cancer hospital Hefei, Anhui, China
- The first affiliated hospital of Anhui medical university Hefei, Anhui, China
- Peking University Third Hospital Beijing, Beijing Municipality, China
- Beijing Cancer Hospital Beijing, Beijing Municipality, China